To evaluate early ambulation in patients who receive the StarClose™ VCS post-percutaneous diagnostic procedure.
To evaluate the StarClose™ VCS in the femoral artery in subjects who are ambulated early post-percutaneous cardiac or peripheral vascular, diagnostic catheterization procedure. The clinical use of vascular closure devices for rapid hemostasis after femoral access was first reported in 1991. 18 participants may be ambulated almost immediately after diagnostic coronary angiography and discharged many hours earlier than currently practiced in most centers utilizing a supine restriction period of 6 hours after diagnostic catheterization.14 After coronary interventions, participant comfort is additionally increased by immediate sheath removal. This early ambulation study is an evaluation of a clip-based technology, which achieves vascular hemostasis with the use of a novel extravascular Nitinol clip to provide an immediate mechanical closure that does not depend upon the body's clotting system. The procedures will be performed in participants who meet specific entrance criteria.
Study Type
OBSERVATIONAL
Enrollment
165
Scripps Memorial Hospital
La Jolla, California, United States
Fuqua Heart Center/ Piedmont Hospital
Atlanta, Georgia, United States
Heart Care Midwest (OSF/St Francis)
Peoria, Illinois, United States
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
The Care Group LLC (St. Vincent's Hospital)
Indianapolis, Indiana, United States
Bay Regional Medical Center
Bay City, Michigan, United States
Minneapolis Heart Institute Foundation/Abbott Northwestern Hospital
Minneapolis, Minnesota, United States
St. Luke's Hospital
Kansas City, Missouri, United States
New York Methodist Hospital
Brooklyn, New York, United States
Buffalo Heart group
Buffalo, New York, United States
North Ohio Research LTD Elyria Regional Medical
Elyria, Ohio, United States
...and 1 more locations